🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will examine the safety and efficacy of the addition of sitaglip...
Status
Completed
Location
Multiple Locations
Start Date
2009-04-15
Trial ID
NCT00885352
Treatments Being Tested
Diabetes mellitus is a group of metabolic diseases caused by multiple etiol...
Status
Unknown
Location
The First Affiliated Hospital of Air Force Medical University (Xijing Hospital)
Start Date
2022-02-07
Trial ID
NCT05214235
Treatments Being Tested
Epidemiologic, social and economic burdens of type 2 diabetes mellitus (T2D...
Status
Completed
Location
Azienda Ospedaliero Universitaria di Parma
Start Date
2020-09-01
Trial ID
NCT04271189
Treatments Being Tested
This study investigated a 4-week adjunctive therapy of either a GLP-1 analo...
Status
Completed
Location
Profil Institut für Stoffwechselforschung GmbH
Start Date
2008-01
Trial ID
NCT00971659
The aim of this study is to explore the effectiveness of liraglutide combin...
Status
Completed
Location
The Third Affiliated Hospital of Sun Yat-sen University
Start Date
2014-08
Trial ID
NCT02147925
After a screening, a 2-week, single-blind placebo run-in, 200 patients will...
Status
Completed
Location
Samsung Medical Center
Start Date
2015-04
Trial ID
NCT02567994
Treatments Being Tested
Phase 3 study to compare treatment with ITCA 650 to sitagliptin when added ...
Status
Withdrawn
Location
Intarcia Therapeutics, Inc
Start Date
2013-02
Trial ID
NCT01455909
Treatments Being Tested
This study was the extension of the LANTU\_C\_02761 study named EASIE and i...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-06
Trial ID
NCT00851903
Treatments Being Tested
Canadian physicians to experience in real life clinical practice the effica...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-01
Trial ID
NCT00833027
Treatments Being Tested
The purpose of this study is to determine if albiglutide is safe and effect...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00838903